| 000 | 01820 a2200505 4500 | ||
|---|---|---|---|
| 005 | 20250516060502.0 | ||
| 264 | 0 | _c20111202 | |
| 008 | 201112s 0 0 eng d | ||
| 022 | _a0394-6320 | ||
| 024 | 7 |
_a10.1177/039463201102400316 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMelillo, Lorella | |
| 245 | 0 | 0 |
_aCombination treatment of flag with non-pegylated liposomal doxorubicin (MYOCET(TM)) in elderly patients with acute myeloid leukemia: a single center experience. _h[electronic resource] |
| 260 |
_bInternational journal of immunopathology and pharmacology _c |
||
| 300 |
_a703-9 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 |
_aAntibiotics, Antineoplastic _xadministration & dosage |
| 650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xadverse effects |
| 650 | 0 | 4 | _aCombined Modality Therapy |
| 650 | 0 | 4 |
_aCytarabine _xadministration & dosage |
| 650 | 0 | 4 | _aDisease-Free Survival |
| 650 | 0 | 4 |
_aDoxorubicin _xadministration & dosage |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aGranulocyte Colony-Stimulating Factor |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLeukemia, Myeloid, Acute _xdrug therapy |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aSurvival Analysis |
| 650 | 0 | 4 |
_aVidarabine _xadministration & dosage |
| 700 | 1 | _aValente, D | |
| 700 | 1 | _aD'Arena, G | |
| 700 | 1 | _aDell'Olio, M | |
| 700 | 1 | _aFalcone, A | |
| 700 | 1 | _aMinervini, M M | |
| 700 | 1 | _aNobile, M | |
| 700 | 1 | _aRossi, G | |
| 700 | 1 | _aSanpaolo, G | |
| 700 | 1 | _aScalzulli, P R | |
| 700 | 1 | _aCascavilla, N | |
| 773 | 0 |
_tInternational journal of immunopathology and pharmacology _gvol. 24 _gno. 3 _gp. 703-9 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1177/039463201102400316 _zAvailable from publisher's website |
| 999 |
_c21213283 _d21213283 |
||